Ronald K. Lloyd

Insider Reports History

Entity
Individual
Location
C/O Mallinckrodt Pharmaceuticals, 675 Mcdonnell Blvd., Hazelwood, MO
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for Ronald K. Lloyd
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ronald K. Lloyd:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AZIYO BIOLOGICS, INC. PRESIDENT AND CEO, Director Restricted Stock Units 39.9K $96.1K $2.41 Mar 8, 2022 Direct
AZIYO BIOLOGICS, INC. PRESIDENT AND CEO, Director Class A Common Stock 31.8K $76.6K $2.41 Mar 8, 2022 Direct
AZIYO BIOLOGICS, INC. PRESIDENT AND CEO, Director Stock Option (Right to Buy) 139K Mar 8, 2022 Direct

Insider Reports Filed by Ronald K. Lloyd

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELUT AZIYO BIOLOGICS, INC. Mar 8, 2022 5 $0 4 Mar 10, 2022 PRESIDENT AND CEO, Director
ELUT AZIYO BIOLOGICS, INC. May 7, 2021 2 $101K 4 May 11, 2021 PRESIDENT AND CEO, Director